Tumour diagnosis tool wins pitch competition
2 Jun 2017
A blood test tool for earlier detection of brain tumours wins Ready, Steady Pitch! competition.
ClinSpec Dx, a simple blood test to detect brain tumours earlier, was the winning pitch when the top 30 Converge Challenge applicants went head-to-head to give 60-second ‘Dragon’s Den’ style pitches to an expert panel and an audience of 120 industry experts.
Dr Holly Butler, a Research Associate at the University of Strathclyde, delivered the winning pitch showing how ClinSpec Dx can change brain tumour diagnosis statistics through earlier detection.
Second place went to mycoBiologics, a portable diagnosis test for fungal infections similar to a pregnancy test, led by Dr Fiona Rudkin, a Royal Society of Edinburgh Enterprise Fellow at the University of Aberdeen.
Third place went to novosound, which has developed sensors that can provide high resolution ultrasound imaging at a fraction of the current cost, revolutionising the medical, dental and veterinary markets, led by Dr Dave Hughes, a Fellow at the University of the West of Scotland.
The 30 finalists will now develop a comprehensive business plan with the top six candidates going forward to the final, competing for a share of the total prize fund of £170,000.
Converge Challenge has three core categories: Converge Challenge: for established ideas; KickStart: for early stage ideas; and Social Enterprise: for ideas that will have a positive impact on social and environmental issues.
The winners of each of the three categories will be announced at a gala awards ceremony at the Glasgow Science Centre on Thursday 28 September.